[TAKAFUL] QoQ TTM Result on 31-Mar-2022 [#1]

Stock
[TAKAFUL] SYARIKAT TAKAFUL MALAYSIA KELUARGA BERHAD
Announcement Date
11-May-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2022
Quarter
31-Mar-2022 [#1]
Profit Trend
QoQ- -3.49%
YoY- 9.69%
Quarter Report
Latest QR
Upcoming QR
TAKAFUL's Result
TAKAFUL's Financial Summary
View:
Show?
TTM Result
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Revenue 3,764,542 3,631,724 3,391,624 3,260,907 3,179,010 3,075,956 3,145,108 12.69%
PBT 500,017 506,374 457,243 445,815 438,700 415,827 425,158 11.38%
Tax -180,944 -106,322 -71,677 -48,152 -26,500 -56,310 -55,652 118.99%
NP 319,073 400,052 385,566 397,663 412,200 359,517 369,506 -9.29%
-
NP to SH 318,517 399,797 385,131 397,053 411,423 358,437 368,433 -9.22%
-
Tax Rate 36.19% 21.00% 15.68% 10.80% 6.04% 13.54% 13.09% -
Total Cost 3,445,469 3,231,672 3,006,058 2,863,244 2,766,810 2,716,439 2,775,602 15.45%
-
Net Worth 1,983,272 2,000,009 1,923,662 1,880,149 1,799,340 1,754,806 1,679,174 11.70%
Dividend
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Div 112,971 999 999 999 999 996 996 2223.07%
Div Payout % 35.47% 0.25% 0.26% 0.25% 0.24% 0.28% 0.27% -
Equity
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Net Worth 1,983,272 2,000,009 1,923,662 1,880,149 1,799,340 1,754,806 1,679,174 11.70%
NOSH 837,305 837,305 837,305 835,622 835,622 835,622 835,622 0.13%
Ratio Analysis
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
NP Margin 8.48% 11.02% 11.37% 12.19% 12.97% 11.69% 11.75% -
ROE 16.06% 19.99% 20.02% 21.12% 22.87% 20.43% 21.94% -
Per Share
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 449.86 433.99 405.51 390.24 381.62 368.10 376.47 12.57%
EPS 38.06 47.78 46.05 47.52 49.39 42.89 44.10 -9.32%
DPS 13.50 0.12 0.12 0.12 0.12 0.12 0.12 2210.46%
NAPS 2.37 2.39 2.30 2.25 2.16 2.10 2.01 11.57%
Adjusted Per Share Value based on latest NOSH - 835,622
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
RPS 449.60 433.74 405.06 389.45 379.67 367.36 375.62 12.69%
EPS 38.04 47.75 46.00 47.42 49.14 42.81 44.00 -9.22%
DPS 13.49 0.12 0.12 0.12 0.12 0.12 0.12 2209.32%
NAPS 2.3686 2.3886 2.2974 2.2455 2.149 2.0958 2.0054 11.70%
Price Multiplier on Financial Quarter End Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 30/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 -
Price 3.44 3.30 3.23 3.63 3.70 4.22 4.35 -
P/RPS 0.76 0.76 0.80 0.93 0.97 1.15 1.16 -24.50%
P/EPS 9.04 6.91 7.01 7.64 7.49 9.84 9.86 -5.60%
EY 11.06 14.48 14.26 13.09 13.35 10.16 10.14 5.94%
DY 3.92 0.04 0.04 0.03 0.03 0.03 0.03 2452.24%
P/NAPS 1.45 1.38 1.40 1.61 1.71 2.01 2.16 -23.27%
Price Multiplier on Announcement Date
31/12/22 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 CAGR
Date 24/02/23 01/11/22 04/08/22 11/05/22 24/02/22 23/11/21 25/08/21 -
Price 3.48 3.32 3.36 3.51 3.57 3.68 4.52 -
P/RPS 0.77 0.76 0.83 0.90 0.94 1.00 1.20 -25.54%
P/EPS 9.14 6.95 7.30 7.39 7.23 8.58 10.25 -7.33%
EY 10.94 14.39 13.70 13.54 13.83 11.66 9.76 7.88%
DY 3.88 0.04 0.04 0.03 0.03 0.03 0.03 2434.89%
P/NAPS 1.47 1.39 1.46 1.56 1.65 1.75 2.25 -24.64%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment